InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-43.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Deluccia Robert J, Director. Director active across 1 company, notably Acurx Pharmaceuticals, Inc.. Aggregated, 4 reports have been recorded. Split: 3 buys · 0 sell. Total volume traded: €144k. Activity tracked since 19 November 2021. The latest transaction was filed on 6 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Deluccia Robert J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
49,261 shares@ US$1.01529.3% of flowCommon StockSEC:0001104659-25-002050:0
Canonical exit: 6 Apr 2025 (T+90)
40,000 shares0Common StockSEC:0001104659-24-001375:0
19,737 shares@ US$3.8044.4% of flowCommon StockSEC:0001104659-22-084316:0
Canonical exit: 25 Oct 2022 (T+90)
5,034 shares@ US$4.90115.1% of flowCommon StockSEC:0001104659-21-142473:0
Canonical exit: 17 Feb 2022 (T+90)
4 of 4 declarations
About Deluccia Robert J
Robert J. DeLuccia is a Director at Acurx Pharmaceuticals, Inc. He contributes to the governance of the company by bringing his expertise in strategy and business development. Robert is involved in key decisions that influence the future of Acurx Pharmaceuticals.
